Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $7.58 M | -98.12% |
2023 | $0.40 B | -21.9% |
2022 | $0.51 B | -20% |
2021 | $0.64 B | 402.3% |
2020 | $0.12 B | -31.62% |
2019 | $0.18 B | -56.08% |
2018 | $0.42 B | 535.89% |
2017 | $67.44 M | -64.21% |
2016 | $0.18 B | -29.02% |
2015 | $0.26 B | 2.16% |
2014 | $0.25 B | 138.9% |
2013 | $0.10 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.13 B | $0.59 B | ๐บ๐ธ USA |
Novartis NVS | $18.64 M | $83.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $10.32 M | $0.31 B | ๐บ๐ธ USA |
Abbott Laboratories ABT | $10.62 M | $0.13 B | ๐บ๐ธ USA |
Eli Lilly LLY | $56.64 M | $0.12 B | ๐บ๐ธ USA |
Amgen AMGN | $52.25 M | $0.21 B | ๐บ๐ธ USA |
Sanofi SNY | $21.22 M | $52.23 M | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $18.31 M | $24.09 M | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | ๐ฎ๐ฑ Israel |